varitect solution for injection 5g/1250iu/50 ml %v/v
biotest pharma gmbh - human plasma protein >95% immunoglobulins immunoglobulin varicella-zoster - solution for injection - 5g/1250iu/50 ml %v/v
varitect 5g/1250iu/50 ml %v/v solution for injection
biotest pharma gmbh - human plasma protein >95% immunoglobulins immunoglobulin varicella-zoster - solution for injection - 5g/1250iu/50 ml %v/v
varitect %v/v solution for injection
biotest pharma gmbh - human plasma protein >95% immunoglobulins immunoglobulin varicella-zoster - solution for injection - %v/v
human albumin biotest 5% solution for infusion 250ml vials
biotest (uk - albumin solution human - solution for infusion - 50mg/1ml
human albumin biotest 20% solution for infusion 50ml vials
biotest (uk - albumin solution human - solution for infusion - 200mg/1ml
human albumin biotest 20% solution for infusion 100ml vials
biotest (uk - albumin solution human - solution for infusion - 200mg/1ml
megalotect solution for infusion 50 units/ml
biotest pharma gmbh - human plasma protein >95% immunoglobulins immunoglobulin cytomegalovirus - solution for infusion - 50 units/ml
megalotect solution for infusion 50 units/ml
biotest pharma gmbh - human plasma protein >95% immunoglobulins immunoglobulin cytomegalovirus - solution for infusion - 50 units/ml
megalotect 50 units/ml solution for infusion
biotest pharma gmbh - human plasma protein >95% immunoglobulins immunoglobulin cytomegalovirus - solution for infusion - 50 units/ml
albiomin 20 %
kamada ltd, israel - plasma protein fraction - solution for infusion - plasma protein fraction 200 mg/ml - protein c - protein c - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendation.